< Press Clips

Correspondence with Dr. med. Franjo Grotenhermen

A letter to research&experience, Frank Fuchs, by
Dr. med. Franjo Grotenhermen, chairman of ACM e.V.

Statement to the therapeutic administering of cannabinoids through hot-air extraction, i.e. vaporizing:

Single cannabinoids or natural composites of cannabinoids of the hemp plant are medically administered orally or through inhalation for the most. Absorption through lungs has pharmacokinetic advantages explored in comparison to absorption through the gastrointestinal tracts. These advantages are in particular faster inception of the effects and a better control of the required doses. Inhalation of cannabinoids by smoking cannabis products however has the disadvantage of about 200 different remains after incineration, known as inherited in tobacco smokes and burning of plants as well – such as Benzpyrene, nitrosamines, and other cell-harming or potentially carcinogenic substances. This disadvantage is avoided by hot-air extraction aka vaporizing of the cannabinoids below the plant material’s burning temperatures. Thus the advantages of administering by inhalation can be adopted without the disadvantages of smoking.

The ACM considers the development and distribution of such inhalators as an initiative worth of support and welcome.

Cologne, Aug 11. 1999
Franjo Grotenhermen